What’s the current state of research into addiction and treatment?
Addiction continuously evolves as societies, substances and the health care industry change. To save lives, we must keep up with these changes and develop innovative, evidence-based approaches to patient care, treatment methods and recovery outcomes. In partnership with faculty from Johns Hopkins University School of Medicine, our work has advanced scientific thought related to key topics in the field, including:
- Treatment outcomes study that evaluates and connects behavioral outcomes, symptoms and trends in inpatient and outpatient treatment models
- Clinical trials and intervention studies which advance our understanding of effective methodologies
- Health services efficacy study, reviewing post-treatment and recovery behavioral statistics to evaluate the lasting effects of treatment
- Basic science inquiry into interactions, clearances and toxicology associated with substance use disorders
A broad goal drives each of our efforts: to improve lives and advance humanity’s understanding of substance use disorder, including its treatments and effects. As our understanding of the disease of addiction evolves, so will our research efforts.
Our research programs are led in partnership by Ashley staff and Andrew Huhn, Ph.D., M.B.A., associate professor in the Department of Psychiatry and Behavioral Studies at The Johns Hopkins University School of Medicine. Dr. Huhn’s research focuses on risk factors for illicit drug relapse and medication strategies to improve opioid use disorder treatment outcomes. Ashley has partnered with Dr. Huhn since 2018 on a number of studies using patient treatment, recovery and outcome data to inform treatment methodologies for Ashley and the medical community at large.
Research Associate, Jami Mayo, earned her Bachelor of Arts in Psychology from UMBC and is currently working towards an MBA with a specialization in health care management, data science and innovation at the Johns Hopkins Carey School of Business. Her current work relates to clinical pharmacology of abused substances, substance abuse liability, behavioral and neuropsychiatric assessments, as well as biomedical device, behavioral and medication-based treatments for substance abuse.
Justin Strickland, Ph.D., is an instructor at Johns Hopkins University School of Medicine in the Department of Psychiatry and Behavioral Sciences. His research focuses on understanding the behavioral and biological processes underlying substance use disorder, including behavioral economics and decision-making science. At Ashley, his work improves our patient experience by identifying individual differences related to positive response to develop, evaluate, and implement novel treatments.